AddLife AB (OSTO:ALIF B) Interest Coverage: 5.02 (As of Jun. 2026) — 67% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:ALIF B AddLife AB OSTO:ALIF B
88 GF Score
Price kr161.40
GF Value kr150.50
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is AddLife AB Interest Coverage?

AddLife AB OSTO:ALIF B -3.58% 88 Interest Coverage is 5.02 as of Jun. 2026, which is 67% below its 10-year median of 15.29. GuruFocus rates OSTO:ALIF B with a GF Score™ of 88/100 and a GF Value™ of kr150.50 (Fairly Valued). The stock has 5 warning signs investors should review. Among 464 Medical Devices & Instruments companies, AddLife AB ranks worse than 76.51% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. AddLife AB's Operating Income for the three months ended in Jun. 2026 was kr236 Mil. AddLife AB's Interest Expense for the three months ended in Jun. 2026 was kr-47 Mil. AddLife AB's interest coverage for the quarter that ended in Jun. 2026 was 5.02. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for AddLife AB's Interest Coverage or its related term are showing as below:

OSTO:ALIF B' s Interest Coverage Range Over the Past 10 Years
Min: 1.58   Med: 15.29   Max: 32.44
Current: 5.19


OSTO:ALIF B's Interest Coverage is ranked worse than
76.51% of 464 companies
in the Medical Devices & Instruments industry
Industry Median: 16.08 vs OSTO:ALIF B: 5.19

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


AddLife AB  (OSTO:ALIF B) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


AddLife AB Interest Coverage Related Terms


AddLife AB Interest Coverage Historical Data

* Premium members only.

The historical data trend for AddLife AB's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

AddLife AB Interest Coverage Chart

AddLife AB Annual Data
Trend Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.74 6.36 1.58 2.39 4.10

AddLife AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.70 3.06 7.86 4.98 5.02

OSTO:ALIF B vs ISRG, BDX, MDLN: Interest Coverage Comparison

For the Medical Instruments & Supplies subindustry, AddLife AB's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AddLife AB Interest Coverage vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's Interest Coverage distribution charts can be found below:

* The bar in red indicates where AddLife AB's Interest Coverage falls into.


OSTO:ALIF B
88GF Score
AddLife AB OSTO:ALIF B
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AddLife AB Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

AddLife AB's Interest Coverage for the fiscal year that ended in Dec. 2025 is calculated as

Here, for the fiscal year that ended in Dec. 2025, AddLife AB's Interest Expense was kr-202 Mil. Its Operating Income was kr829 Mil. And its Long-Term Debt & Capital Lease Obligation was kr2,831 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2025 )/Interest Expense (A: Dec. 2025 )
=-1*829/-202
=4.10

AddLife AB's Interest Coverage for the quarter that ended in Jun. 2026 is calculated as

Here, for the three months ended in Jun. 2026, AddLife AB's Interest Expense was kr-47 Mil. Its Operating Income was kr236 Mil. And its Long-Term Debt & Capital Lease Obligation was kr2,932 Mil.

Interest Coverage=-1* Operating Income (Q: Jun. 2026 )/Interest Expense (Q: Jun. 2026 )
=-1*236/-47
=5.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 5.02 mean?
AddLife AB (OSTO:ALIF B) has a Interest Coverage of 5.02 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on AddLife AB and its competitors. This is 67% below median its historical median of 15.29. Over the past decade, AddLife AB's Interest Coverage has ranged from 1.58 to 32.44. According to the industry distribution chart, AddLife AB ranks #355 out of 464 companies in the Medical Devices & Instruments industry, placing it in the top 76.5%.
Is AddLife AB's Interest Coverage too high?
AddLife AB's current Interest Coverage of 5.02 is 67% below median its 10-year median of 15.29. Over the past 10 years, this metric has ranged from a low of 1.58 to a high of 32.44. The Medical Devices & Instruments industry median Interest Coverage is 16.08. AddLife AB's value of 5.02 is 68.8% below this industry median. Based on the distribution chart, AddLife AB ranks #355 out of 464 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, AddLife AB has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does AddLife AB's Interest Coverage compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, AddLife AB ranks #355 out of 464 companies for Interest Coverage. This places AddLife AB in the lower half of its industry. The industry median Interest Coverage is 16.08. AddLife AB's value of 5.02 is 68.8% below this benchmark. Historically, AddLife AB's own Interest Coverage has ranged from 1.58 to 32.44 over the past decade. While the company's 10-year median is 15.29 vs. the industry median of 16.08, AddLife AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.08, based on 464 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AddLife AB's current Interest Coverage of 5.02 is 68.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on AddLife AB and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AddLife AB's current Interest Coverage is 5.02, which is 67% below median its own 10-year median of 15.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AddLife AB stock overvalued right now?
Based on GuruFocus' analysis, AddLife AB (OSTO:ALIF B) is currently considered Fairly Valued. The stock's GF Value™ is kr150.50, compared to a current price of kr161.40 — trading 7.2% above its estimated fair value. The current Interest Coverage is 5.02, which is 67% below median its 10-year median of 15.29 and 68.8% below the Medical Devices & Instruments industry median of 16.08. AddLife AB's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For AddLife AB (OSTO:ALIF B), the current Interest Coverage is 5.02 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AddLife AB (OSTO:ALIF B) Overvalued in 2026?

Based on GuruFocus' analysis, AddLife AB stock appears to be overvalued. The current stock price of kr161.40 is trading 7.2% above its estimated GF Value™ of kr150.50. GuruFocus considers AddLife AB to be Fairly Valued.

Key valuation signals for OSTO:ALIF B:

  • Interest Coverage: 5.02 (67% below median its 10-year median of 15.29)
  • GF Value™: kr150.50 vs. price of kr161.40 (7.2% above fair value)
  • GF Score™: 88/100 with 5 warning signs
  • Industry Position: 68.8% below the Medical Devices & Instruments median (#355 of 464)

No single metric tells the full story. See the OSTO:ALIF B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AddLife AB Business Description

Address Brunkebergstorg 5, Box 3145, Stockholm, SWE, 103 62
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech. The Labtech segment provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service to laboratories in medicine, research, academia and the food and pharmaceutical industries. The Medtech segment includes a range that spans from basic consumables to instruments for surgical procedures, welfare technology, and assistive devices for the elderly and disabled. The majority of revenue is derived from the Medtech segment.
88GF Score

Get the complete analysis for OSTO:ALIF B

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr161.40
Price
kr150.50
GF Value